Citius Pharmaceuticals (CTXR) - News Mentions

Sign up to add (CTXR) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Gentex Corporation
Gentex Corporation
GNTX		 0 0%
AutoZone
AutoZone
AZO		 0 0%
Genuine Parts Company
Genuine Parts Company
GPC		 0 0%
Standard Motor Products
Standard Motor Products
SMP		 1 0%
Advance Auto Parts
Advance Auto Parts
AAP		 0 0%
Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split
November 21
Citius Pharmaceuticals stock hits 52-week low at $0.16
November 21
Citius Pharmaceuticals (NASDAQ: CTXR) Announces Successful Closure of Offering
November 20
Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering
November 18
HC Wainwright Issues Pessimistic Forecast for CTXR Earnings
November 16
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering
November 15
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab and LYMPHIR in Cancer Patients
November 11
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors
November 10
Arkadios Wealth Advisors Acquires 50,000 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
November 2
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Short Interest Update
October 1
Citius Pharma progresses with FDA on Mino-Lok approval
November 25
Acute respiratory distress syndrome
October 28

How often is Citius Pharmaceuticals mentioned in the news?

Citius Pharmaceuticals was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Citius Pharmaceuticals performing compared to its industry peers?

Citius Pharmaceuticals underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Citius Pharmaceuticals in the last month?

There has been no significant change in the number of news mentions for Citius Pharmaceuticals' compared to the last month.

Why is it important to track news mentions for Citius Pharmaceuticals?

By monitoring mentions in the news for Citius Pharmaceuticals, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Citius Pharmaceuticals, ultimately improving their investment strategies.

Sign up and get more insights on Citius Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact